Emergent BioSolutions Inc. (NYSE:EBS) is seeking M&A. Robert G. Kramer President and Chief Executive Officer said during the Third Quarter 2021 Financial Results Conference Call, "Our third quarter operational results demonstrate that our business remains resilient and poised for growth in line with our strategy. We continue on our path of both organic opportunities and potential M&A informed by prudent capital deployment, all aimed at generating enhanced shareholder value".